Philips’ strategic partnership with NicoLab set to accelerate stroke diagnosis and treatment

NETHERLANDS – Royal Philips, a global leader in health technology, has partnered with NicoLab, a MedTech stroke care company, to increase leverage on Philips’ stroke portfolio.

Philips has a deep portfolio of stroke care solutions and a strong commitment to further innovation in this field.

The partnership with NicoLab brings a cloud-based, end-to-end artificial intelligence (AI) based stroke triage and management solution, StrokeViewer, that aims to improve patient outcome by optimizing the stroke workflow.

Together with the recently expanded stroke capabilities of Philips Image Guided Therapy System, Azurion, this new partnership significantly advances Philips’ commitment to improving outcomes for people who suffer a stroke.

Stroke is a disease that affects the arteries leading to and within the brain and is the No. 5 cause of death and a leading cause of disability in the United States.

A stroke occurs when a blood vessel that carries oxygen and nutrients to the brain is either blocked by a clot or bursts (or ruptures).

When that happens, part of the brain cannot get the blood (and oxygen) it needs, so the brain cells die.

Globally, one in four adults over the age of 25 will suffer a stroke in their lifetime and according to the U.S. National Stroke Association, 40% of stroke victims experience moderate to severe impairments that require special needs for the rest of their lives, with another 25% continuing to suffer minor impairments.

The key to reducing the risk of death or disability is to get stroke patients treated as quickly as possible. Physicians in an emergency stroke setting are fighting the clock and are under intense pressure to make optimal treatment decisions.

Despite the imperative for speed, care teams currently lose valuable time due to gaps in communication, information, and access to stroke expertise. 

“The biggest gain for faster treatment for stroke patients is in the workflow,” said Professor Dr. Wim van Zwam, Interventional Radiologist at Maastricht University Medical Center. “Reducing the throughput time of patients requires faster exchange of critical patient information, such as high-quality medical images, between hospitals and departments, in order to decide on the best patient treatment.”

Philips is also pioneering a new approach to speed up stroke treatment for early time-window stroke patients (less than six hours after stroke onset) by bypassing diagnostic CT or MR scans at certain types of stroke center.

Currently, Philips stroke portfolio includes solutions for stroke monitoring and communication in ambulances, tele-stroke patient assessment, diagnostic imaging and analysis, image-guided therapy, neurological monitoring and assessment, and more.

Newer Post

Thumbnail for Philips’ strategic partnership with NicoLab set to accelerate stroke diagnosis and treatment

Merck Foundation provides scholarships to Mauritian doctors in commitment to build healthcare capacity

Older Post

Thumbnail for Philips’ strategic partnership with NicoLab set to accelerate stroke diagnosis and treatment

UNBS certifies 166 firms to make face masks and sanitizers to alleviate pandemic effects

Be the first to leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.